Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications
Open accessThe DOI matches its Crossref record; 130 of the 132 references it cites were found in a registry or an index.
Abstract
Individuals with diabetes are at increased risk for bacterial, mycotic, parasitic, and viral infections. The severe acute respiratory syndrome (SARS)-CoV-2 (also referred to as COVID-19) coronavirus pandemic highlights the importance of understanding shared disease pathophysiology potentially informing therapeutic choices in individuals with type 2 diabetes (T2D). Two coronavirus receptor proteins, angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase-4 (DPP4) are also established transducers of metabolic signals and pathways regulating inflammation, renal and cardiovascular physiology, and glucose homeostasis. Moreover, glucose-lowering agents such as the DPP4 inhibitors, widely used in subjects with T2D, are known to modify the biological activities of multiple immunomodulatory substrates. Here, we review the basic and clinical science spanning the intersections of diabetes, coronavirus infections, ACE2, and DPP4 biology, highlighting clinical relevance and evolving areas of uncertainty underlying the pathophysiology and treatment of T2D in the context of coronavirus infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“however, just like for ACE inhibitors, there is currently insufficient scientific evidence to judge whether use of DPP4 inhibitors impacts adversely on type 2 diabetes patients with COVID-19 (28).”
From ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency (2020) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · cited 1×
“The results of several large studies examining the cardiovascular safety of GLP-1R agonists did not reveal imbalances in rates of inflammatory disorders or severe infections (113) (114) (115) (116) .”
ResultSemaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900 · cited 1×
“The results of several large studies examining the cardiovascular safety of GLP-1R agonists did not reveal imbalances in rates of inflammatory disorders or severe infections (113) (114) (115) (116) .”
ResultHamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 9×
“1), and generates vasodilatory Ang (1-7), collectively modulating often opposing actions of Ang II and ACE through Ang and angiotensin (1-7) receptors.”
BackgroundInfluentialGrasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469 · cited 2×
“form ACE2(1-740), however the biological importance of sACE2 remains uncertain.”
BackgroundCase-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470 · cited 2×
“Consistent with these findings, results of large trials examining the safety of saxagliptin, alogliptin, sitagliptin, and linagliptin in humans with T2D at risk for cardiovascular or renal disease did not reveal clinically relevant safety concerns related to infections, immune or inflammatory disorders (96-100).”
BackgroundResult
Research works printed but not linked: 1
- Audit I. ICNARC Report on COVID-19 in Critical Care. In. April 10 2020 ed: London, UK: Intensive Care National Audit & Research Centre (ICNARC); 2020. https:// www.icnarc.org/About/Latest-News/2020/04/04/ Report-On-2249-Patients-Critically-Ill-With-Covid-19
Cited by
Items 201–300 of 433
Pediatric Type 2 Diabetes Presentation During the COVID-19 Pandemic
Neyman, A., Nabhan, Z. M., Woerner, S., & Hannon, T. S. (2021) · Clinical Pediatrics · doi:10.1177/00099228211064030 · Cited by 15
COVID-19 Pandemisi ve Diabetes Mellitus
Kutlutürk, F. (2020) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.746139 · Cited by 15
Lee, J. H. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110739 · Cited by 15
Sex differences in mortality in the intensive care unit patients with severe COVID-19
Moiseev, S. V., Brovko, M., Tao, E., Bulanov, N. M., Анатольевна, А. Л., & Fomin, V. V. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.09.031 · Cited by 15
Scott, T. M., Jensen, S., & Pickett, B. E. (2021) · F1000Research · doi:10.12688/f1000research.52412.1 · Cited by 14
Risk factors for the early development of septic shock in patients with severe COVID-19
Glybochko, P. V., Fomin, V. V., Moiseev, S. V., Avdeev, S. N., Yavorovskiy, A. G., Brovko, M., Umbetova, K., Алиев, В. А., Bulanova, E. L., Bondarenko, I. B., et al. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.11.000780 · Cited by 14
Govender, Y., Shalekoff, S., Ebrahim, O., Waja, Z., Chaisson, R. E., Martinson, N. A., & Tiemessen, C. T. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108824 · Cited by 14
García-Mena, J., Corona-Cervantes, K., Cuervo-Zanatta, D., Benítez-Guerrero, T., Vélez-Ixta, J. M., Zavala-Torres, N. G., Villalobos-Flores, L. E., Hernández-Quiroz, F., Perez‐Cruz, C., Murugesan, S., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i41.7065 · Cited by 14
Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
Preckel, B., Schultz, M. J., Vlaar, A. P. J., Hulst, A. H., Hermanides, J., de Jong, M. D., Schlack, W. S., Stevens, M. F., Weenink, R. P., & Hollmann, M. W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051495 · Cited by 13
Katsiki, N., Gómez‐Huelgas, R., Mikhailidis, D. P., & Pérez‐Martínez, P. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14833 · Cited by 13
Sunlight Exposure and Phototherapy: Perspectives for Healthy Aging in an Era of COVID-19
Nakano, T., Chiang, K., Chen, C.-C., Chen, P.-J., Lai, C.-Y., Hsu, L., Ohmori, N., Goto, T., Chen, C., & Goto, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010950 · Cited by 13
Wong, C. K. H., Lui, D. T. W., Lui, A. Y. C., Kwok, A. C. Y., Low, M. C. H., Lau, K. T. K., Au, I. C. H., Xiong, X., Chung, M. S. H., Lau, E. H. Y., et al. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101307 · Cited by 13
Albai, O., Frandeș, M., Sima, A. C., Timar, B., Vlad, A., & Timar, R. Z. (2022) · Medicina · doi:10.3390/medicina58070848 · Cited by 13
Foresta, A., Fernandez, M. L. O., Macaluso, G., Roncaglioni, M. C., Tettamanti, M., Fortino, I., Leoni, O., Genovese, S., & Baviera, M. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.02.007 · Cited by 13
Luk, A. O. Y., Ng, S. S., & Holt, R. I. G. (2021) · Diabetic Medicine · doi:10.1111/dme.14547 · Cited by 13
Wang, B., Yuan, S., Ruan, S., Ning, X., Li, H., Liu, Y., & Li, X. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1210800 · Cited by 12
Huang, X., Zhang, K.-J., Jiang, J., Jiang, S., Lin, J.-B., & Lou, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.801260 · Cited by 12
Zhou, Y., Li, J., Wang, L., Zhu, X., Zhang, M., & Zheng, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.833679 · Cited by 12
Severity of COVID-19 and diabetes mellitus: there is still a lot to be learned
Rodacki, M. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000261 · Cited by 12
Coate, K. C., Cha, J., Shrestha, S., Wang, W., Gonçalves, L. M., Almaça, J., Kapp, M. E., Fasolino, M., Morgan, A., Dai, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.31.275719 · Cited by 12
Hong, T. S., Gonzalez, J., Nahass, R., & Brunetti, L. (2020) · Pharmacy · doi:10.3390/pharmacy8040208 · Cited by 11
Alves, M., Fernandes, M. A., Bahat, G., Bénétos, A., Clemente, H., Grodzicki, T. K., Martínez‐Sellés, M., Mattace-Raso, F. U. S., Rajkumar, C., Ungar, A., et al. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00504-5 · Cited by 11
Covid-19 & Obesity: Beyond Bmi
Nadolsky, K. Z., Hurley, D. L., & Garvey, W. T. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0302 · Cited by 11
Challenges in Women with Diabetes During the COVID-19 Pandemic
Priya, G., Bajaj, S., Grewal, E., Maisnam, I., Chandrasekharan, S., & Selvan, C. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.2.100 · Cited by 11
Miftode, E. G., Miftode, I.-L., Coman, I., Prepeliuc, C. S., Obreja, M., Stămăteanu, L. O., Părângă, T. G., Leca, D. A., & Plesca, C. E. (2021) · Healthcare · doi:10.3390/healthcare9070788 · Cited by 11
Kifle, Z. D., Woldeyohanins, A. E., & Demeke, C. A. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100134 · Cited by 11
The diabetic lung: An easy target for SARS‐CoV ‐2?
Caruso, I., & Giorgino, F. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3346 · Cited by 11
Diabetes mellitus and COVID-19: A review and management guidance for South Africa.
Coetzee, A., Taljaard, J., Hugo, S., Conradie, M., Conradie-Smit, M., & Dave, J. A. (2020) · South African Medical Journal · doi:10.7196/samj.2020.v110i8.14881 · Cited by 11
Munteanu, C., Paun, D., ȘUȚĂ, A.-M., Florescu, S. A., & Onose, G. (2020) · Balneo Research Journal · doi:10.12680/balneo.2020.363 · Cited by 11
Diabetic ketoacidosis precipitated by COVID-19 in patient with newly diagnosed diabetes mellitus
Xhardo, E., Kapisyzi, P., & Rada, A. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.5.2021.241521 · Cited by 10
Stabilizing Cellular Barriers: Raising the Shields Against COVID-19
Hanchard, J., Capó-Vélez, C. M., Deusch, K., Lidington, D., & Bolz, S.-S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.583006 · Cited by 10
Shin, C. H., Kim, K., Jeeva, S., & Kang, S. (2021) · Cells · doi:10.3390/cells10061412 · Cited by 10
Freire, J. E. D. C., Monteiro-Júnior, J. E., Pinheiro, D. P., Lima, G. E. D. C. P., do Amaral, C. L., Veras, V. R., Madeira, M. P., Freire, E. B. L., Ozório, R. G., Fernandes, V. O., et al. (2022) · 3 Biotech · doi:10.1007/s13205-022-03406-w · Cited by 10
DIABETES MELLITUS, OBESIDADE E MAUS HÁBITOS DE VIDA: SUA RELAÇÃO COM A COVID-19
Monteiro, A. R., Barros, L. A. D. S., Albernaz, P. C. S., Vieira, V. B. D. A., Barroso, V. D. D. M. P., & Rodrigues, M. C. D. C. (2020) · Revista Científica da Faculdade de Medicina de Campos · doi:10.29184/1980-7813.rcfmc.377.vol.15.n2.2020 · Cited by 10
Popovic, D. S., Παπάνας, Ν., Koufakis, T., Kotsa, K., Almahmeed, W. A., Al‐Rasadi, K., Al-Alawi, K., Banach, M., Banerjee, Y., Ceriello, A., et al. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2019-1111 · Cited by 9
Endothelial pulsatile shear stress is a backstop for COVID-19
Sackner, M. A., & Adams, J. A. (2020) · Emerging Topics in Life Sciences · doi:10.1042/etls20200260 · Cited by 9
Endocrine Flawed In COVID-19 Era
Akter, F., Ahmad, R., & Haque, M. (2021) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v20i5.55416 · Cited by 9
COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments
Gilyazova, I. R., Timasheva, Y., Karunas, A. S., Kazantseva, A. V., Sufianov, A. A., Михайлович, М. А., Korytina, G. F., Wang, Y., Фанилевич, Г. И., & Хуснутдинова, Э. К. (2023) · Non-coding RNA Research · doi:10.1016/j.ncrna.2023.02.007 · Cited by 9
Developmental Impacts of Epigenetics and Metabolism in COVID-19
Naik, N. C., Patel, M., & Sen, R. (2024) · Journal of Developmental Biology · doi:10.3390/jdb12010009 · Cited by 8
Transcriptional profiles associated with coronary artery disease in type 2 diabetes mellitus
Nevado, J. B., la Paz, E. M. C. C., Paz-Pacheco, E. T., Jasul, G., Aman, A. Y. C. L., Deguit, C. D. T., Pedro, J. V. B. S., & Francisco, M. D. G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1323168 · Cited by 8
Singh, A. K., & Singh, R. (2020) · Journal of Diabetology · doi:10.4103/jod.jod_53_20 · Cited by 8
Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
Kloc, M., Ghobrial, R. M., Lewicki, S., & Kubiak, J. Z. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00665-3 · Cited by 8
Solving one of the pieces of the puzzle: COVID-19 and type 2 diabetes
Pérez‐Martínez, P., Carrasco-Sánchez, F. J., Carretero‐Gómez, J., & Gómez‐Huelgas, R. (2020) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2020.05.004 · Cited by 8
Obesity, Diabetes Mellitus, and Metabolic Syndrome: Review in the Era of COVID-19
Abiri, B., Ahmadi, A. R., Hejazi, M., & Amini, S. (2022) · Clinical Nutrition Research · doi:10.7762/cnr.2022.11.4.331 · Cited by 9
Muñoz‐Carrillo, J. L., Gutiérrez-Coronado, O., Villalobos‐Gutiérrez, P. T., Valencia, M. S. V., Chávez-Ruvalcaba, F., Vázquez-Alcaraz, S. J., Rivera‐Lozada, O., & Barboza, J. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188756 · Cited by 7
Stepanova, G. (2021) · Biologia Futura · doi:10.1007/s42977-021-00092-2 · Cited by 7
Wang, W., Chai, Z., Cooper, M. E., Zimmet, P., Guo, H., Ding, J., Yang, F., Lin, X., Chen, X., Wang, X., et al. (2022) · Pathogens · doi:10.3390/pathogens11080902 · Cited by 7
Chiang, C.-Y., Kuo, W., Lin, Y., Kuo, C., Shih, C.-Y., Lin, P., Lin, S., Ho, T., Huang, C., & Shibu, M. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.953438 · Cited by 7
Covid-19: A new cause of “provoked” A-β+ Ketosis-Prone Diabetes
Gaba, R., & Balasubramanyam, A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108147 · Cited by 7
Modarelli, R. E., Balikcioglu, P. G., Hendrix, G., DeRusso, M., & Ozment, C. P. (2021) · AACE Clinical Case Reports · doi:10.1016/j.aace.2021.05.007 · Cited by 6
IMPACT OF ANTIDIABETIC DRUGS ON RISK AND OUTCOME OF COVID-19 INFECTION: A REVIEW
Zainal, A. A., & Merkhan, M. M. (2022) · Military Medical Science Letters · doi:10.31482/mmsl.2022.004 · Cited by 6
Diabète et COVID-19 : les leçons de CORONADO
Cariou, B., Gourdy, P., Hadjadj, S., Pichelin, M., & Wargny, M. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.12.010 · Cited by 6
Proceso de enfermería aplicado a un paciente con SARS-CoV-2 y Diabetes Mellitus 2
de la Cruz, J. F. R. V., Valtier, M. C. G., Ramírez-Hernández, M. M., Morales, M. D. L. Á. P., & Fonseca, M. P. (2020) · SANUS · doi:10.36789/sanus.vi16.210 · Cited by 6
Pathan, F., Selim, S., Fariduddin, M., Rahman, M. H., Ashrafuzzaman, S., Afsana, F., Qureshi, N. K., Hossain, T., Saifuddin, M., Kamrul-Hasan, A. B. M., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s293688 · Cited by 6
Tu, C., Sue, S.-P., Hsu, W., Huang, H., Wen, W., Lin, I., Chen, K., Sheu, N., Huang, S.-H., & Lee, M. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14491 · Cited by 6
Main causes of complicated COVID-19 in patients with diabetes mellitus
Halushko, O. A., Loskutov, О. А., Тріщинська, М. А., Kuchynska, I. A., & Boliuk, M. V. (2021) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.17.4.2021.237723 · Cited by 6
What we know about COVID-19 and its treatment
YAKUT, Z. A. Ç., Sakarcan, S., & Şener, G. (2020) · Journal of Research in Pharmacy · doi:10.35333/jrp.2020.215 · Cited by 6
Association of hypertension and diabetes with COVID-19 severity in comparison to healthy patients
Al‐Jumaili, M. H. A., Ismail, M., Hussein, A., & Najeeb, O. G. (2025) · Journal of Circulating Biomarkers · doi:10.33393/jcb.2025.3561 · Cited by 5
Kow, C. S., Ramachandram, D. S., & Hasan, S. S. (2023) · Health Science Reports · doi:10.1002/hsr2.1549 · Cited by 5
Klein, K. R., Abrahamsen, T. J., Kahkoska, A. R., Alexander, G. C., Chute, C. G., Haendel, M. A., Hong, S., Mehta, H. B., Moffitt, R. A., Stürmer, T., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01562-1 · Cited by 5
Ouchi, D., Vilaplana-Carnerero, C., de Dios, V., Giner‐Soriano, M., & Morros, R. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.10.001 · Cited by 5
Flavonoids and other polyphenols against SARS-CoV-2
Rehman, S. U., Shafqat, F., Fatima, B., Nawaz, M. N., & Niaz, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95047-3.00014-9 · Cited by 5
Bogler, O., Raissi, A., Colacci, M., Beaman, A., Biering‐Sørensen, T., Cressman, A. M., Detsky, A. S., Gosset, A., Lassen, M. C. H., Kandel, C. E., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.02.005 · Cited by 5
Pathophysiologic Basis of Connected Health Systems
Shaikh, Y., & Gibbons, M. C. (2023) · Journal of Medical Internet Research · doi:10.2196/42405 · Cited by 5
Predictors of COVID-19 outcome in type 2 diabetes mellitus: a hospital-based study
Elsayed, A. M., Elsayed, M. S., Mansour, A., Mahedy, A. W., Araby, E., Morsi, M. H., & Abdelmoniem, R. O. (2024) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-023-00266-5 · Cited by 5
Guide on diabetes and COVID-19 for healthcare professionals in Bangladesh
Bhowmik, B., Ahmed, T., Afsana, F., Qureshi, N., Siddiquee, T., Pathan, F., Amin, F., Moreira, N. C. D. V., Samad, M., Ashrafuzzaman, S., et al. (2020) · Journal of Diabetology · doi:10.4103/jod.jod_51_20 · Cited by 5
SARS-CoV-2 infection in a pediatric patient with cystic fibrosis
Páez-Velásquez, J. S., Romero-Uribe, I. E., Castilla-Peón, M. F., Lezana, J. L., & Chávez-López, A. (2021) · Boletín Médico del Hospital Infantil de México · doi:10.24875/bmhim.20000216 · Cited by 5
Menekli, T., Yaprak, B., Türeyen, A., & Şentürk, S. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.08.005 · Cited by 5
Stratakis, C. A., Laybutt, D. R., Laudet, V., & Klinge, C. M. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110863 · Cited by 5
Morello, C. M., Mnatzaganian, C. L., & Painter, N. A. (2026) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2025.250158r1 · Cited by 5
Zhao, M., Han, X., Fan, H. X., Liang, C., Wang, H., Zhang, X., Zhao, S., Guo, C., Liu, Z., & Zhang, T. (2024) · Liver International · doi:10.1111/liv.16136 · Cited by 4
Corcillo, A., Saqib, A., Sithamparanathan, N., Khanam, A., Williams, J., Gulati, A., Kariyawasam, D., & Karalliedde, J. J. (2022) · International Journal of Endocrinology · doi:10.1155/2022/8030765 · Cited by 4
Li, X., Ren, Y., & Yan, T. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/4492574 · Cited by 4
RetractedJimbo, M., Saito, S., Uematsu, T., Hanaki, H., Otori, K., Shibuya, K., & Ando, W. (2023) · BMC Public Health · doi:10.1186/s12889-023-16401-4 · Cited by 4
Hu, W., Tan, J., Lin, Y.-T., Tao, Y., & Zhou, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31405 · Cited by 4
Dipeptidyl-Peptidase 4 (Cd26): a Possible Therapeutic Target in Covid-19
Galimberti, S. (2020) · LOJ Pharmacology and Clinical Research · doi:10.32474/lojpcr.2020.02.000128 · Cited by 4
Chen, S., Lin, W., Wen, J., Xie, B., Chen, L., & Chen, G. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-1982 · Cited by 4
Peña-Valenzuela, A. N., Flores-Montes, G. V., Inzunza-Cervantes, G., Ornelas-Aguirre, J. M., Ponce-Peraza, M. A., & López-López, R. M. (2021) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.20000095 · Cited by 4
Coronavirus Infection an Obese Patient (Literature Review)
Panova, E. I., & Pimankina, M. S. (2021) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2021-11-3-209-216 · Cited by 4
Mistry, S., Gouripeddi, R., & Facelli, J. C. (2021) · JAMIA Open · doi:10.1093/jamiaopen/ooab063 · Cited by 4
The Top 100 Most Cited Manuscripts in Retinopathy of Prematurity: A Bibliometric Analysis
Zhang, Z., Yang, W., Lv, H., Huang, L., Yao, T., & He, Y. (2023) · Seminars in Ophthalmology · doi:10.1080/08820538.2023.2177115 · Cited by 4
Los alimentos de origen vegetal en el centro de la alimentación en los tiempos de la Covid-19
Matos, C. M., & Basabe-Tuero, B. (2020) · Revista Cubana de Alimentación y Nutrición · Cited by 4
Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome
Nakajima, K. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4187 · Cited by 4
Li, Y., Lin, X., Zou, K., Du, J., Li, Q., Zhong, L., & Jiang, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1534733 · Cited by 3
Predictors of severe course of new coronavirus infection (COVID-19): study design
Mishchenko, T. A., Ermakova, P. A., Ermakova, A. A., Tseller, L. P., Рогожкина, Ю. А., Verteletskaya, M. I., Burakevich, O. A., & Kardashina, Z. Z. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.11.201402 · Cited by 3
Eczacılıkta Güncel Araştırmalar
Yamalı, C., Erdönmez, E., Yuca, H., Kalaycı, B., Gökgöz, S., Paşayeva, L., Arslan, A. K. K., Şerbetçi, T., Aydoğan, Y. M., Yüce, H., et al. (2023) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2541 · Cited by 3
Glucose metabolism disorders associated with COVID-19: clinical and morphological study
Каронова, Т. Л., Mikhailova, A. A., Lagutina, D. I., Vorobeva, O. M., Grigoreva, D. O., Sterkhova, K. A., Алексеевна, М. В., Геннадьевна, М. А., Chernikova, A. T., Mitrofanova, L. B., et al. (2023) · Diabetes Mellitus · doi:10.14341/dm13041 · Cited by 3
Covid-19 Aging and Chronic Diseases
Cornelli, U., Belcaro, G., Rosaria, C. M., Martino, R., & Roberto, C. (2020) · Microbiology & Infectious Diseases · doi:10.33425/2639-9458.1096 · Cited by 3
COVID-19'lu diabetic hastanın bakımı
Mencütekin, Y. K., & Gençtürk, N. (2021) · Sağlık ve Yaşam Bilimleri Dergisi · doi:10.33308/2687248x.202131217 · Cited by 3
İLİN, S., & Kuşkonmaz, Ş. M. (2022) · Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · doi:10.20492/aeahtd.922692 · Cited by 3
Al‐Taie, A., Arueyingho, O., Khoshnaw, J., & Hafeez, A. (2022) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2022.2086265 · Cited by 3
COVID-19 e Diabetes Mellitus: O Impacto de Duas Pandemias
Oliveira, P., Louro, J., Gil, P., & Andrade, L. (2022) · Acta Médica Portuguesa · doi:10.20344/amp.16758 · Cited by 3
Deshmukh, R. A., & Roy, U. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.1.12 · Cited by 3
Tackling obesity during the COVID‐19 pandemic
Akirov, A., Cahn, A., Prato, S. D., Home, P. D., Gaal, L. V., Chan, J. C. N., Ning, G., & Raz, I. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3393 · Cited by 3
PERKEMBANGAN TERAPI DIABETES MELLITUS TIPE 2 PADA PASIEN YANG TERINFEKSI COVID-19
Balqis, A. Y., Ramdhani, H., & Amelia, E. K. (2021) · Journal of Experimental and Clinical Pharmacy (JECP) · doi:10.52365/jecp.v1i2.244 · Cited by 3
He, Y., Tan, J., & Han, X. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/4147365 · Cited by 3
RetractedStuhr, A., & Furber, S. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820930030 · Cited by 3
Mjulwa, S. (2023) · DUT Open Scholar (Durban University of Technology) · doi:10.51415/10321/5090 · Cited by 3
The mechanisms underlying COVID-19 induced insulin resistance: a narrative review
Zhu, B., Qu, S., Li, J., Deng, W., Shen, W., & Chen, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1781679 · Cited by 2
Obesidade e COVID-19: Uma revisão integrativa
Serejo, A. H. H., dos Santos, J., de Melo, M. F., & Dutra, L. M. A. (2020) · Revista Científica Multidisciplinar Núcleo do Conhecimento · doi:10.32749/nucleodoconhecimento.com.br/saude/obesidade-e-covid-19 · Cited by 2
Metadata
- Authors
- Drucker, D. J.
- Affiliations
- Mount Sinai Hospital (CA)
- Corresponding author
- Drucker, Daniel J
- ORCID
- Drucker, Daniel J
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2020-04-15
- Volume
- 41
- Issue
- 3
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC7184382
- OpenAlex
- W3015989800
- Cited by
- 399
- References
- 132
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 13 · 2023: 37 · 2022: 72 · 2021: 100 · 2020: 162
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk Fonden (NNF19SA0035502)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- type 2 diabetes, COVID-19 pandemic, SARS-CoV-2, ACE2, dipeptidyl peptidase IV, DPP-4 inhibitors, glucose-lowering agents, immunomodulation, glucose homeostasis, inflammation
- MeSH terms
- Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Insulin, Peptidyl-Dipeptidase A, Lung, Obesity, Pneumonia, Viral, Receptors, Virus, Risk Factors, Serine Endopeptidases, Coronavirus Infections, Dipeptidyl Peptidase 4, Gastrointestinal Tract, Dipeptidyl-Peptidase IV Inhibitors, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.